All stock lists
Unlock the score
CVRx, Inc. (NASDAQ:CVRX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
1.45+0.03 (+2.11%)
Market cap
$38.6M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 30, 2021
Website
Insider Score
/ 100
CVRX Insider Score
CVRx, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
CVRX analyst forecast
CVRX analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CVRX 12-month price target
$7.17+394.5% upsideaverage of 3 firms
$13.00High
$3.50Low
Best analysts covering CVRX
- Canaccord Genuity43%success rate · 7 calls
- Cantor Fitzgerald0%success rate · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CVRX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Canaccord Genuity | — | $5.00 | +68.4% | — | 2026-09-22 | |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-08-17 |
| Lake Street | Hold | $3.50 | +28.2% | Downgraded | 2026-08-07 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-14 |
| Canaccord Genuity | Buy | $10.00 | +75.7% | Reiterated | 2026-02-13 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-11-06 |
| Cantor Fitzgerald | Overweight | $13.00 | +30.3% | Reiterated | 2025-11-06 | |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-08-05 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-05-09 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2025-05-09 |
| — | Lake Street | Buy | — | — | Reiterated | 2025-04-08 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-04-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-02-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-05 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2025-01-17 |
| — | William Blair | Outperform | — | — | Upgraded | 2025-01-14 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-12-09 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-11-04 |
| Piper Sandler | Overweight | $16.00 | +24.0% | Reiterated | 2024-10-30 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-10-30 |
| — | Lake Street | Buy | — | — | Reiterated | 2024-10-30 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-10-23 |
| Cantor Fitzgerald | — | $14.00 | +75.9% | — | 2024-09-10 | |
| — | Lake Street | Buy | — | — | Reiterated | 2024-08-26 |
| Piper Sandler | Overweight | $13.00 | +40.2% | Reiterated | 2024-07-30 | |
| Canaccord Genuity | Buy | $15.00 | +61.8% | Reiterated | 2024-07-30 | |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-07-11 |
| Lake Street | Buy | $12.00 | +58.1% | Reiterated | 2024-07-11 | |
| Loop Capital Markets | — | $18.00 | +125.1% | — | 2024-06-05 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-05-01 |
| — | Lake Street | Buy | — | — | Reiterated | 2024-05-01 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2024-05-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-05-01 |
| — | William Blair | Market Perform | — | — | Downgraded | 2024-05-01 |
| Craig-Hallum | — | $23.00 | +148.1% | — | 2024-05-01 | |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-01-26 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-01-26 |
| — | Lake Street | Buy | — | — | Reiterated | 2023-12-27 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-12-20 |
| — | Lake Street | Buy | — | — | Reiterated | 2023-05-03 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-02-10 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-02-07 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-01-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-11-02 |
CVRX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-12 | -0.42 | -0.46 | $15.8M | $16.0M |
| 2026-05-11 | -0.51 | -0.50 | $14.5M | $14.8M |
| 2026-08-06 | -0.52 | -0.53 | $15.5M | $15.7M |
| 2026-11-05 | -0.49 | 0.00 | $13.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.